SOPHARMA AD: Notification for disclosure of share participation

opublikowano: 2016-11-16 16:42

Spis treści:

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załącznikĂłw:
Current_report_101_Alianz_below_5%_16112016_ENG.doc (REPORT)

	POLISH FINANCIAL SUPERVISION AUTHORITY
				UNI - EN REPORT No		101	/	2016
	Date of issue:		2016-11-16
	Short name of the issuer
	SOPHARMA AD
	Subject
	Notification for disclosure of share participation
	Official market - legal basis
	art. 17. 1 MAR.
	Unofficial market - legal basis
	Contents of the report:
	Sopharma AD (the “Company”) announces that on 16 November 2016 the Company received a notification for the sale of 342 680 shares, representing 0.25% of its capital, by ZUPF Allianz Bulgaria. After the transaction the share of ZUPF Allianz Bulgaria in the capital of Sopharma AD reached 4.80%. The date of the registration of the transaction with the Central Depository is 11 November 2016.
	Annexes
	File				Description
	Current report 101 Alianz below 5% 16112016 ENG.docCurrent report 101 Alianz below 5% 16112016 ENG.doc				Notification for disclosure of share participation

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification
of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

16

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

	SIGNATURE OF PERSONS REPRESENTING THE COMPANY
	Date	Name	Position / Function	Signature
	2016-11-16	Ognian Donev	Executive director